BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lakatos PL, Kiss LS. Current status of thiopurine analogues in the treatment in Crohn's disease. World J Gastroenterol 2011; 17(39): 4372-4381 [PMID: 22110262 DOI: 10.3748/wjg.v17.i39.4372]
URL: https://www.wjgnet.com/1007-9327/full/v17/i39/4372.htm
Number Citing Articles
1
Igor G. Bakulin, Maria I. Skalinskaya, Igor V. Maev, Ekaterina V. Skazyvaeva, Mariia S. Zhuravleva, Larisa B. Gaikovaya, Natalia V. Bakulina, Aleksei I. Ermakov, Ekaterina S. Alekseenko, Kristina N. Ivanova, Mikhail V. Solovev. Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety managementTerapevticheskii arkhiv 2021; 93(8): 841 doi: 10.26442/00403660.2021.08.200982
2
Carla Caldas Marques, Morgana T. Castelo-Branco, Rodrigo G. Pacheco, Fernanda Buongusto, Alyson do Rosário, Alberto Schanaider, Robson Coutinho-Silva, Heitor S.P. de Souza. Prophylactic systemic P2X7 receptor blockade prevents experimental colitisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014; 1842(1): 65 doi: 10.1016/j.bbadis.2013.10.012
3
Olof Modén, Bengt Mannervik. Redox and Cancer Part AAdvances in Cancer Research 2014; 122: 199 doi: 10.1016/B978-0-12-420117-0.00006-2
4
Gordon W Moran, Marie-France Dubeau, Gilaad G Kaplan, Hong Yang, Bertus Eksteen, Subrata Ghosh, Remo Panaccione. Clinical predictors of thiopurine-related adverse events in Crohn's diseaseWorld Journal of Gastroenterology 2015; 21(25): 7795-7804 doi: 10.3748/wjg.v21.i25.7795